Pravastatin Does Not Improve Survival in Small - Cell Lung Cancer
Median overall survival of 10.6 versus 10.7 months for pravastatin versus placebo added to chemo
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Internal Medicine, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news
More News: Cancer | Cancer & Oncology | Internal Medicine | Lung Cancer | Pravastatin | Respiratory Medicine | Statin Therapy